InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Carter Martha J., Directeur Réglementaire. Officer active across 1 company, notably Albireo Pharma, INC.. Cumulatively, 10 filings have been published. Split: 0 buy · 6 sells. Total volume traded: €60k. History available since 18 January 2022. The latest transaction was filed on 19 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Carter Martha J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
3,656 sharesCommon StockSEC:0001209191-23-014753:0
55,000 shares0Common StockSEC:0001209191-23-005336:0
55,000 shares0Common StockSEC:0001209191-23-004951:0
120 shares@ US$43.807.0% of flowCommon StockSEC:0001209191-23-004438:0
938 shares@ US$43.904455.3% of flowCommon StockSEC:0001209191-23-004224:0
104 shares@ US$19.57643.0% of flowCommon StockSEC:0001209191-22-054486:0
106 shares@ US$24.67733.7% of flowCommon StockSEC:0001209191-22-043110:0
103 shares@ US$32.924714.6% of flowCommon StockSEC:0001209191-22-025529:0
423 shares@ US$24.516242.7% of flowCommon StockSEC:0001209191-22-004799:0
10,800 shares0Common StockSEC:0001209191-22-004067:0
10 of 10 declarations
About Carter Martha J.
Martha J. Carter is the Chief Regulatory Officer at ALBIREO PHARMA, INC. She is responsible for overseeing regulatory and compliance matters within the company. With a strong background in the pharmaceutical sector, Martha plays a key role in ensuring that Albireo's products meet current standards and regulations. Her commitment to compliance is essential in maintaining the company's reputation.
